146 related articles for article (PubMed ID: 10598361)
1. Should a hospital without a neurologist use t-PA to treat stroke?
Krieger DW
Cleve Clin J Med; 1999; 66(10):585-6. PubMed ID: 10598361
[No Abstract] [Full Text] [Related]
2. Meningovascular syphilis and improvement with tissue-plasminogen activator (T-PA).
Han JH; Lee CC; Crupi RS
Am J Emerg Med; 2004 Sep; 22(5):426-7. PubMed ID: 15490387
[No Abstract] [Full Text] [Related]
3. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
[TBL] [Abstract][Full Text] [Related]
4. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.
Eckert B; Kucinski T; Neumaier-Probst E; Fiehler J; Röther J; Zeumer H
Cerebrovasc Dis; 2003; 15(4):258-63. PubMed ID: 12686789
[TBL] [Abstract][Full Text] [Related]
5. Hyperacute stroke therapy with tissue plasminogen activator.
Alberts MJ
Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
[TBL] [Abstract][Full Text] [Related]
6. In reply.
Edlow JA; Smith EE
Ann Emerg Med; 2013 Oct; 62(4):433. PubMed ID: 24054100
[No Abstract] [Full Text] [Related]
7. The lytic lottery.
Ellison D
Ann Emerg Med; 2013 Oct; 62(4):432-3. PubMed ID: 24054099
[No Abstract] [Full Text] [Related]
8. Stroke teams and acute stroke pathways: one emergency department's two-year experience.
Jahnke HK; Zadrozny D; Garrity T; Hopkins S; Frey JL; Christopher M
J Emerg Nurs; 2003 Apr; 29(2):133-9. PubMed ID: 12660695
[No Abstract] [Full Text] [Related]
9. Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department.
; Brown MD; Burton JH; Nazarian DJ; Promes SB
Ann Emerg Med; 2015 Sep; 66(3):322-333.e31. PubMed ID: 26304253
[No Abstract] [Full Text] [Related]
10. IV tissue plasminogen activator for stroke in the community: what we know and don't know 10 years after FDA approval.
Furlan AJ
Stroke; 2006 Feb; 37(2):281. PubMed ID: 16397163
[No Abstract] [Full Text] [Related]
11. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
[TBL] [Abstract][Full Text] [Related]
12. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
[TBL] [Abstract][Full Text] [Related]
13. Expectations for tPA is pathway to litigation.
ED Manag; 2011 Feb; 23(2):18-9. PubMed ID: 21400969
[No Abstract] [Full Text] [Related]
14. Stroke thrombolysis in Mombasa--an outreach service.
Cohen D
Pract Neurol; 2011 Dec; 11(6):372-4. PubMed ID: 22100952
[No Abstract] [Full Text] [Related]
15. Soduko.
Hughes T
Pract Neurol; 2011 Dec; 11(6):375. PubMed ID: 22100953
[No Abstract] [Full Text] [Related]
16. Lack of t-PA use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria.
Engelstein E; Margulies J; Jeret JS
Am J Emerg Med; 2000 May; 18(3):257-60. PubMed ID: 10830678
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous thrombolysis with rt-PA in stroke: experience of the French military hospital of Toulon from September 2003 to June 2009].
Faivre A; Sagui E; Canini F; Wybrecht D; Bounolleau P; Grapperon J; Alla P; Valance J
Rev Neurol (Paris); 2010 Nov; 166(11):909-20. PubMed ID: 20452634
[TBL] [Abstract][Full Text] [Related]
18. Alteplase for stroke: money and optimistic claims buttress the "brain attack" campaign.
Lenzer J
BMJ; 2002 Mar; 324(7339):723-9. PubMed ID: 11909792
[No Abstract] [Full Text] [Related]
19. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes.
Scott PA; Silbergleit R
Ann Emerg Med; 2003 Nov; 42(5):611-8. PubMed ID: 14581912
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type of the Canadian alteplase for stroke effectiveness study registry.
Libman R; Kwiatkowski T
Stroke; 2007 Sep; 38(9):e88. PubMed ID: 17673802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
